147 related articles for article (PubMed ID: 16547230)
1. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4+CD25+ T cell development.
Kashiwada M; Cattoretti G; McKeag L; Rouse T; Showalter BM; Al-Alem U; Niki M; Pandolfi PP; Field EH; Rothman PB
J Immunol; 2006 Apr; 176(7):3958-65. PubMed ID: 16547230
[TBL] [Abstract][Full Text] [Related]
2. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.
Ott VL; Tamir I; Niki M; Pandolfi PP; Cambier JC
J Immunol; 2002 May; 168(9):4430-9. PubMed ID: 11970986
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3.
Robson JD; Davidson D; Veillette A
Mol Cell Biol; 2004 Mar; 24(6):2332-43. PubMed ID: 14993273
[TBL] [Abstract][Full Text] [Related]
4. The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.
Waterman PM; Marschner S; Brandl E; Cambier JC
Immunol Lett; 2012 Mar; 143(1):122-30. PubMed ID: 22370159
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2.
Dong S; Corre B; Foulon E; Dufour E; Veillette A; Acuto O; Michel F
J Exp Med; 2006 Oct; 203(11):2509-18. PubMed ID: 17043143
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions.
Senis YA; Antrobus R; Severin S; Parguiña AF; Rosa I; Zitzmann N; Watson SP; García A
J Thromb Haemost; 2009 Oct; 7(10):1718-26. PubMed ID: 19682241
[TBL] [Abstract][Full Text] [Related]
7. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.
Kepley CL; Taghavi S; Mackay G; Zhu D; Morel PA; Zhang K; Ryan JJ; Satin LS; Zhang M; Pandolfi PP; Saxon A
J Biol Chem; 2004 Aug; 279(34):35139-49. PubMed ID: 15151996
[TBL] [Abstract][Full Text] [Related]
8. Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8
Lahmidi S; Yousefi M; Dridi S; Duplay P; Pearson A
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490594
[TBL] [Abstract][Full Text] [Related]
9. Loss of Dok-1 and Dok-2 in mice causes severe experimental colitis accompanied by reduced expression of IL-17A and IL-22.
Waseda M; Arimura S; Shimura E; Nakae S; Yamanashi Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):135-142. PubMed ID: 27450811
[TBL] [Abstract][Full Text] [Related]
10. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.
O'Neill SK; Getahun A; Gauld SB; Merrell KT; Tamir I; Smith MJ; Dal Porto JM; Li QZ; Cambier JC
Immunity; 2011 Nov; 35(5):746-56. PubMed ID: 22078222
[TBL] [Abstract][Full Text] [Related]
11. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
12. Bilevel control of B-cell activation by the inositol 5-phosphatase SHIP.
Brauweiler AM; Tamir I; Cambier JC
Immunol Rev; 2000 Aug; 176():69-74. PubMed ID: 11043768
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the Timing of Action of the PAG Adaptor Using Quantitative Proteomics Analysis of Primary T Cells.
Reginald K; Chaoui K; Roncagalli R; Beau M; Goncalves Menoita M; Monsarrat B; Burlet-Schiltz O; Malissen M; Gonzalez de Peredo A; Malissen B
J Immunol; 2015 Dec; 195(11):5472-81. PubMed ID: 26512138
[TBL] [Abstract][Full Text] [Related]
14. SHIP limits immunoregulatory capacity in the T-cell compartment.
Collazo MM; Wood D; Paraiso KH; Lund E; Engelman RW; Le CT; Stauch D; Kotsch K; Kerr WG
Blood; 2009 Mar; 113(13):2934-44. PubMed ID: 19136659
[TBL] [Abstract][Full Text] [Related]
15. Dok-1 and Dok-2 Regulate the Formation of Memory CD8+ T Cells.
Laroche-Lefebvre C; Yousefi M; Daudelin JF; Charpentier T; Tarrab E; Klinck R; Lamarre A; Labrecque N; Stäger S; Duplay P
J Immunol; 2016 Nov; 197(9):3618-3627. PubMed ID: 27664281
[TBL] [Abstract][Full Text] [Related]
16. Dok-1 is a positive regulator of IL-4 signalling and IgE response.
Inoue A; Yasuda T; Yamamoto T; Yamanashi Y
J Biochem; 2007 Aug; 142(2):257-63. PubMed ID: 17827176
[TBL] [Abstract][Full Text] [Related]
17. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
[TBL] [Abstract][Full Text] [Related]
18. Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.
Oki S; Limnander A; Yao PM; Niki M; Pandolfi PP; Rothman PB
Cell Cycle; 2005 Feb; 4(2):310-4. PubMed ID: 15655368
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase.
Gérard A; Favre C; Garçon F; Némorin JG; Duplay P; Pastor S; Collette Y; Olive D; Nunès JA
Oncogene; 2004 Feb; 23(8):1594-8. PubMed ID: 14647425
[TBL] [Abstract][Full Text] [Related]
20. Role of Dok-1 and Dok-2 in leukemia suppression.
Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
